Gene · 977
Papers2,195
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,195
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptomic Studies of Antidepressant Action in Rodent Models of Depression: A First Meta-Analysis. | Int J Mol Sci | 2022 | 36362329 | PubTator, text mining | PubMed |
| Medium Extracellular Vesicles-A Qualitative and Quantitative Biomarker of Prostate Cancer. | Biomedicines | 2022 | 36359374 | PubTator, text mining | PubMed |
| A Novel apaQTL-SNP for the Modification of Non-Small-Cell Lung Cancer Susceptibility across Histological Subtypes. | Cancers (Basel) | 2022 | 36358727 | PubTator, text mining | PubMed |
| Exosomes─Nature's Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics. | ACS Nano | 2022 | 36354238 | PubTator, text mining | PubMed |
| Proteomics of Extracellular Vesicle in Glioblastoma. | Brain Tumor Res Treat | 2022 | 36347634 | PubTator, text mining | PubMed |
| Diverse clinical and genetic characteristics of six cases of inherited epidermolysis bullosa. | Exp Ther Med | 2022 | 36340603 | PubTator, text mining | PubMed |
| An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection. | Comput Biol Med | 2022 | 36334362 | PubTator, text mining | PubMed |
| 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution. | J Adv Res | 2022 | 36328741 | PubTator, text mining | PubMed |
| The importance of being CAFs (in cancer resistance to targeted therapies). | J Exp Clin Cancer Res | 2022 | 36324182 | PubTator, text mining | PubMed |
| Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient Blood. | ACS Omega | 2022 | 36312392 | PubTator, text mining | PubMed |
| Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. | Cell Stress | 2022 | 36311892 | PubTator, text mining | PubMed |
| Screening potential biomarkers of cholangiocarcinoma based on gene chip meta-analysis and small-sample experimental research. | Front Oncol | 2022 | 36300097 | PubTator, text mining | PubMed |
| Temporal proteomic analyses of human lung cells distinguish high pathogenicity influenza viruses and coronaviruses from low pathogenicity viruses. | Front Microbiol | 2022 | 36299731 | PubTator, text mining | PubMed |
| Mutation Analysis of Thin Basement Membrane Nephropathy. | Genes (Basel) | 2022 | 36292665 | PubTator, text mining | PubMed |
| The Role of Genomics and Proteomics in Lung Cancer Early Detection and Treatment. | Cancers (Basel) | 2022 | 36291929 | PubTator, text mining | PubMed |
| Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer. | Proteomes | 2022 | 36278695 | PubTator, text mining | PubMed |
| In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation. | iScience | 2022 | 36262311 | PubTator, text mining | PubMed |
| Genetic susceptibility loci for Chlamydia trachomatis endometrial infection influence expression of genes involved in T cell function, tryptophan metabolism and epithelial integrity. | Front Immunol | 2022 | 36248887 | PubTator, text mining | PubMed |
| Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle- and exosome-like populations of KIT-containing extracellular vesicles. | J Extracell Vesicles | 2022 | 36239715 | PubTator, text mining | PubMed |
| Functional Heterogeneity of Bone Marrow Mesenchymal Stem Cell Subpopulations in Physiology and Pathology. | Int J Mol Sci | 2022 | 36233230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/977/papers?page=17